Skip to content
Recall Observatory FDA recall evidence

Drug product

Levoxyl (levothyroxine sodium) tablets, USP, 50 mcg, packaged in a) 100-count bottles (NDC 60793-851-01) and b) 1000-count bottles (NDC 60793-851-10), Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620

D-422-2013

April 30, 2013

Class II

Product summary

Firm
King Legacy, a wholly owned subsidiary of Pfizer
Event
Event 65172
Status
Terminated
Classification
Class II
Quantity
195,699 bottles
Official record key
drug-enforcement:D-422-2013

Official wording

Reason: Subpotent Drug: The products were below specification for potency at the expiry stability point.

Code information: Lot # a) 64934, Exp. 4/13; 65059, Exp. 5/13; 65179, Exp. 4/13; 65630, Exp. 7/13; 65916, Exp. 8/13; 66367, Exp. 10/13; and 66718, Exp. 11/13; b) 64338, Exp. 4/13; 64932, Exp. 4/13; 65060, Exp. 5/13; 65235, Exp. 6/13; 65853, Exp. 6/13; and 65962, Exp. 7/13

Distribution pattern: Nationwide and Puerto Rico

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Subpotent